Company intelligence
Hera Biotech
Advancing the Standard of Care in Women's Health Diagnostics
Biotechnology Research
San Antonio, US
12 employees
Founded 2020
2 public signals
About Hera Biotech
Hera Biotech is building the first scalable diagnostic platform for endometriosis and cervical cancer—two of the most underdiagnosed conditions affecting women globally.
Verified activity
Signals from Hera Biotech
2 published signals
Research & Knowledge
Hera Biotech published a study in Nature Medicine analyzing 2,904 maternal blood proteins collected at about 12 weeks of pregnancy to identify ISM2 as a biomarker associated with later preeclampsia or fetal growth restriction.
Reported by Somer Baburek, MBA
Research & Knowledge
Hera Biotech published a study in AJOG examining more than 1,200 women with surgically confirmed endometriosis and comparing risk factors and co-existing conditions across different lesion types.
Reported by Somer Baburek, MBA